½ÃÀ庸°í¼­
»óǰÄÚµå
1463091

¼¼°èÀÇ ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : ½ÃÇè À¯Çüº°, »ùÇà À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)

Latex Agglutination Test Kits Market Share, Size, Trends, Industry Analysis Report, By Test Type (Antibody Detection, Antigen Testing, and Others); By Sample Type; By End User; By Region; Segment Forecast, 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 116 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°è ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 10¾ï 2,983¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

»ç¿ëÀÇ ¿ëÀ̼º, ªÀº ³³±â, ½Å¼ÓÇÑ Áø´Ü ¹× Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ȯÀÚÀÇ °á°ú Àüü¸¦ °³¼±ÇÏ´Â ´É·Â µîÀÇ À¯ÀÍÇÑ Æ¯¼º¿¡ ÀÇÇØ ÀÀÁý °Ë»ç ŰƮ¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ POC ±â¼úÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖÀ½ ÇÏÁö¸¸ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ÀÌ Å°Æ®ÀÇ »ç¿ëÀº °¨¿°°úÀÚ°¡ ¸é¿ª ÁúȯÀÇ Á¶±â Áø´ÜÀ» À§ÇØ ´Ù¾çÇÑ °Ç°­ °ü¸® ȯ°æ¿¡¼­ ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

°Ô´Ù°¡, ÀÚµ¿È­ ½Ã½ºÅÛÀÇ °¡¿ë¼º Áõ°¡¿Í Å×½ºÆ® ½ºÆ®¸³ ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¼±À¸·Î ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮÀÇ Àû¿ë ¿µ¿ªÀÌ Å©°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÅÈï°¨¿°Áõ°ú ½Å°¨¿°ÁõÀ» °ËÃâÇÏ´Â ´É·ÂÀ» °®Ãá °Ë»ç ŰƮ °³¹ßÀ» À§ÇÑ ´ë±â¾÷ÀÇ ³ë·ÂÀÌ È°¹ßÇØÁö°í Àֱ⠶§¹®¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ°¡ ´õ¿í »ý±æ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 12¿ù, Gold Standard Diagnostics´Â »ì¸ð³Ú¶ó±Õ, ·¹Áö¿À³Ú¶ó±Õ, ½ºÅ¸ÇÊ·ÎÄÚÄ¿½º ¾Æ¿ì·¹¿ì½ºÀÇ Äݷδϸ¦ È®ÀÎÇϱâ À§ÇÑ °£ÆíÇÏ°í ºü¸£°í ºñ¿ë È¿À²ÀûÀÎ ¹æ¹ýÀÎ Microgen ½Å¼Ó ¶óÅØ½º ÀÀÁý ½ÃÇèÀ» ¹ßÇ¥Çß½À´Ï´Ù.

½ÅÈï º´¿øÃ¼¸¦ °ËÃâÇϰí ÀÌ·¯ÇÑ °Ë»çÀÇ ¹Î°¨µµ¿Í ƯÀ̼ºÀ» Çâ»ó½ÃŰ´Â »õ·Î¿î Çõ½ÅÀ» Á¦°øÇϱâ À§ÇØ ±â¾÷Àº Á¡Á¡ ¸ÂÃãÈ­µÈ ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù, Spectacular Labs´Â ½Å¼ÓÇϰí Á¤È®Çϸç ÀÚµ¿È­µÈ º´¿øÃ¼ °Ë»ç Ç÷§ÆûÀ» Ãâ½ÃÇÒ °èȹÀ» ¹ßÇ¥Çß½À´Ï´Ù. »õ·Ó°Ô °³¹ßµÈ ¼Ö·ç¼ÇÀ» ÅëÇØ ±â¾÷Àº º´¿øÃ¼¸¦ ½±°Ô °¨ÁöÇÒ ¼ö ÀÖ¾î °Ë»ç ±â°üÀÌ ºñ¿ë È¿À²ÀûÀ¸·Î ¾÷¹«¸¦ È®ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ °Ç°­ °ü¸® ÇöÀå¿¡¼­´Â ¸¹Àº ȯÀÚ°¡ ¸é¿ª·ÂÀ» ³·Ã߰ųª ¼ö¼úÀ» ¹Þ±â ¶§¹®¿¡ ½ÉÇÑ È²»ö Æ÷µµ»ó ±¸±Õ °¨¿°À» ÀÏÀ¸Å³ À§Çè°ú ÀáÀç·ÂÀÌ ³ô¾ÆÁ³À¸¸ç ƯÈ÷ Ȳ»ö Æ÷µµ ±¸±ÕÀÇ ºÎÇϸ¦ ¸ð´ÏÅ͸µÇϱâ À§ÇÑ Çõ½ÅÀûÀÎ ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

°¨¿°Áõ ȯÀÚ ¼ö Áõ°¡¸¦ ¹è°æÀ¸·Î Ç׿ø °Ë»ç ºÐ¾ß°¡ ÇöÀúÇÑ Á¡À¯À²À» Â÷Áö

Ç÷¾× ºÎ¹®ÀÌ ´ëºÎºÐÀÇ Á¡À¯À²À» Â÷ÁöÇßÁö¸¸, À̰ÍÀº ¸¹Àº Áúº´ÀÇ °ËÃâ¿ë »ùÇ÷μ­ Ç÷¾×ÀÌ ³Î¸® ä¿ëµÇ°í ÀÖ´Â °ÍÀÌ ¹è°æ¿¡ ÀÖ´Ù.

µ¶¸³Çü ÀÓ»ó ½ÇÇè½Ç ºÎ¼­´Â ÷´Ü Áø´Ü Àåºñ¸¦ °®Ãá °Ë»ç½Ç ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó °¡Àå ³ôÀº ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÏ¹Ì´Â °¨¿°ÀÇ À¯ÇàÀÌ Áõ°¡ÇÏ°í °Ç°­ °ü¸® ÀÎÇÁ¶ó°¡ È®¸³µÇ¾î ¼¼°è ½ÃÀåÀ» µ¶Á¡

ÁÖ¿ä ½ÃÀå ±â¾÷Àº Bio-Rad Laboratories, Eurofins Technologies, Mast Group, Pro Lab Diagnostics, Thermo Fisher Scientific, Atlas Medical µîÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå ÀλçÀÌÆ®

  • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ÃÖÁ¾ »ç¿ëÀÚ ½º³À¼¦
  • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • °Ë»ç ŰƮÀÇ »ç¿ë°ú ÀÀ¿ë ºÐ¾ßÀÇ È®´ë¿Í R&D Ȱµ¿ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù.
      • ÀÇ½Ä Çâ»ó°ú ½ºÅ©¸®´× ÇÁ·Î±×·¥ °­È­
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • ´ëü ±â¼ú·ÎºÎÅÍÀÇ °æÀï
  • PESTEL ºÐ¼®
  • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀåÀÇ ÃÖÁ¾ »ç¿ëÀÚ µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ½ÃÇè À¯Çüº° ¼¼°è ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • Ç×ü °ËÃâ
  • Ç׿ø °Ë»ç
  • ±âŸ

Á¦6Àå »ùÇà À¯Çüº° ¼¼°è ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ÇÇ
  • ¼Òº¯
  • ³úô¼ö
  • ±âŸ

Á¦7Àå ÃÖÁ¾ »ç¿ëÀÚº° ¼¼°è ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • º´¿ø º´¼³ÀÇ ¿¬±¸¼Ò
  • µ¶¸³ ÀÓ»ó ½ÇÇè½Ç
  • ±âŸ

Á¦8Àå Áö¿ªº° ¼¼°è ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå Æò°¡, Áö¿ªº°(2019-2032³â)
  • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ½ÃÇè À¯Çüº°(2019-2032³â)
    • ºÏ¹Ì : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • ºÏ¹Ì : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, »ùÇà À¯Çüº°(2019-2032³â)
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ¹Ì±¹
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ij³ª´Ù
  • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - À¯·´
    • À¯·´ : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ½ÃÇè À¯Çüº°(2019-2032³â)
    • À¯·´ : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • À¯·´ : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, »ùÇà À¯Çüº°(2019-2032³â)
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ¿µ±¹
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ÇÁ¶û½º
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - µ¶ÀÏ
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ÀÌÅ»¸®¾Æ
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ½ºÆäÀÎ
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ³×´ú¶õµå
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ·¯½Ã¾Æ
  • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ½ÃÇè À¯Çüº°(2019-2032³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, »ùÇà À¯Çüº°(2019-2032³â)
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - Áß±¹
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - Àεµ
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ¸»·¹À̽þÆ
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ÀϺ»
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - Àεµ³×½Ã¾Æ
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - Çѱ¹
  • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ½ÃÇè À¯Çüº°(2019-2032³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, »ùÇà À¯Çüº°(2019-2032³â)
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - UAE
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - À̽º¶ó¿¤
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ½ÃÇè À¯Çüº°(2019-2032³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå, »ùÇà À¯Çüº°(2019-2032³â)
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ¸ß½ÃÄÚ
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ºê¶óÁú
    • ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦9Àå °æÀï ±¸µµ

  • È®´ë ¹× Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • ÆÄÆ®³Ê½Ê/Çù¾÷/°è¾à/°ø°³

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Arlington Scientific Inc.
  • Atlas Medical GmbH
  • Bio-Rad Laboratories Inc.
  • Biotec
  • Calbiotech
  • Creative Diagnostics
  • Eurofins Technologies
  • Hardly Diagnostics
  • HiMedia Laboratories
  • Liofilchem Srl
  • Mast Group Ltd.
  • Ngaio Diagnostics
  • Pro Lab Diagnostics Inc.
  • Thermo Fisher Scientific
JHS 24.05.14

The global latex agglutination test kits market size is expected to reach USD 1,029.83 million by 2032, according to a new study by Polaris Market Research. The report "Latex Agglutination Test Kits Market Share, Size, Trends, Industry Analysis Report, By Test Type (Antibody Detection, Antigen Testing, and Others); By Sample Type; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising adoption of various POC technologies including agglutination test kits because of its beneficial characteristics such as ease of use, quick turnaround time, and ability to improve overall patient outcomes through enabling rapid diagnosis and treatment, are the primary factors fostering market's growth. The use of these kits is increasing rapidly in various healthcare settings for the early diagnosis of infectious and autoimmune diseases.

Furthermore, the growing availability of automated systems and continuous improvements in test strip technology have significantly expanded the application area of latex agglutination test kits. Moreover, the rising efforts of leading companies towards developing test kits with ability to detect emerging or new infectious diseases, are further anticipated to create lucrative growth opportunities.

For instance, in December 2023, Gold Standard Diagnostics, introduced Microgen rapid latex agglutination tests, that are easy, fast, & cost-efficient methods for identification of the Salmonella, Legionella, & Staphylococcus aureus colonies.

Companies are increasingly focusing towards the development of customize latex agglutination test kits with aim to detect the emerging pathogens and bringing new innovations that lead to improved sensitivity and specificity of these tests, thus, there is an emerging opportunity for companies in the market. For instance, in July 2023, Spectacular Labs, announced about its plan to launch a fast, accurate, and automated pathogen testing platform. The newly developed solution will enable companies to easily detect pathogens and testing laboratories to scale their operations cost-effectively.

In addition, as large number of patients in healthcare settings have been compromising immune systems or having surgeries, there is an increased risk and higher chance of developing serious staph infections that fuels the need for innovated latex agglutination test kits to monitor the load of bacteria particularly S. aureus.

Latex Agglutination Test Kits Market Report Highlights

Antigen testing segment accounted for notable share, on account of rising number of people suffering with infectious disease

Blood segment held the majority share, that is driven by widespread adoption of blood as sample for detection for numerous diseases

Standalone clinical laboratories segment will grow at highest growth rate, due to rising number of these laboratories equipped with advanced diagnostic equipment

North America dominated the global market, owing to rising prevalence of infectious diseases and presence of well-established healthcare infrastructure

The key market players include Bio-Rad Laboratories, Eurofins Technologies, Mast Group, Pro Lab Diagnostics, Thermo Fisher Scientific, and Atlas Medical

Polaris Market Research has segmented the latex agglutination test kits market report based on test type, sample type, end user, and region:

Latex Agglutination Test Kits, Test Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Antibody Detection
  • Antigen Testing
  • Others

Latex Agglutination Test Kits, Sample Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Blood
  • Urine
  • Cerebrospinal
  • Others

Latex Agglutination Test Kits, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals-based Laboratories
  • Standalone Clinical Laboratories
  • Others

Latex Agglutination Test Kits, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Latex Agglutination Test Kits Market Insights

  • 4.1. Latex Agglutination Test Kits Market - End User Snapshot
  • 4.2. Latex Agglutination Test Kits Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing use and application areas of test kits and rising R&D activities are key factors expected to boost market growth.
      • 4.2.1.2. Increasing Awareness and Screening Programs.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Competition from Alternative Technologies.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Latex Agglutination Test Kits Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Latex Agglutination Test Kits Market, by Test Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
  • 5.3. Antibody Detection
    • 5.3.1. Global Latex Agglutination Test Kits Market, by Antibody Detection, by Region, 2019-2032 (USD Million)
  • 5.4. Antigen Testing
    • 5.4.1. Global Latex Agglutination Test Kits Market, by Antigen Testing, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Latex Agglutination Test Kits Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Latex Agglutination Test Kits Market, by Sample Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
  • 6.3. Blood
    • 6.3.1. Global Latex Agglutination Test Kits Market, by Blood, by Region, 2019-2032 (USD Million)
  • 6.4. Urine
    • 6.4.1. Global Latex Agglutination Test Kits Market, by Urine, by Region, 2019-2032 (USD Million)
  • 6.5. Cerebrospinal
    • 6.5.1. Global Latex Agglutination Test Kits Market, by Cerebrospinal, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Latex Agglutination Test Kits Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Latex Agglutination Test Kits Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
  • 7.3. Hospitals-based Laboratories
    • 7.3.1. Global Latex Agglutination Test Kits Market, by Hospitals-based Laboratories, By Region, 2019-2032 (USD Million)
  • 7.4. Standalone Clinical Laboratories
    • 7.4.1. Global Latex Agglutination Test Kits Market, by Standalone Clinical Laboratories, By Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Latex Agglutination Test Kits Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Latex Agglutination Test Kits Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Latex Agglutination Test Kits Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Latex Agglutination Test Kits Market - North America
    • 8.3.1. North America: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.3.4. Latex Agglutination Test Kits Market - U.S.
      • 8.3.4.1. U.S.: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.3.5. Latex Agglutination Test Kits Market - Canada
      • 8.3.5.1. Canada: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
  • 8.4. Latex Agglutination Test Kits Market - Europe
    • 8.4.1. Europe: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.4.4. Latex Agglutination Test Kits Market - UK
      • 8.4.4.1. UK: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.4.5. Latex Agglutination Test Kits Market - France
      • 8.4.5.1. France: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.4.6. Latex Agglutination Test Kits Market - Germany
      • 8.4.6.1. Germany: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.4.7. Latex Agglutination Test Kits Market - Italy
      • 8.4.7.1. Italy: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.4.8. Latex Agglutination Test Kits Market - Spain
      • 8.4.8.1. Spain: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.4.9. Latex Agglutination Test Kits Market - Netherlands
      • 8.4.9.1. Netherlands: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.4.10. Latex Agglutination Test Kits Market - Russia
      • 8.4.10.1. Russia: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
  • 8.5. Latex Agglutination Test Kits Market - Asia Pacific
    • 8.5.1. Asia Pacific: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.5.4. Latex Agglutination Test Kits Market - China
      • 8.5.4.1. China: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.5.5. Latex Agglutination Test Kits Market - India
      • 8.5.5.1. India: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.5.6. Latex Agglutination Test Kits Market - Malaysia
      • 8.5.6.1. Malaysia: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.5.7. Latex Agglutination Test Kits Market - Japan
      • 8.5.7.1. Japan: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.5.8. Latex Agglutination Test Kits Market - Indonesia
      • 8.5.8.1. Indonesia: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.5.9. Latex Agglutination Test Kits Market - South Korea
      • 8.5.9.1. South Korea: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
  • 8.6. Latex Agglutination Test Kits Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.6.4. Latex Agglutination Test Kits Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.6.5. Latex Agglutination Test Kits Market - UAE
      • 8.6.5.1. UAE: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.6.6. Latex Agglutination Test Kits Market - Israel
      • 8.6.6.1. Israel: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.6.7. Latex Agglutination Test Kits Market - South Africa
      • 8.6.7.1. South Africa: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
  • 8.7. Latex Agglutination Test Kits Market - Latin America
    • 8.7.1. Latin America: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.7.4. Latex Agglutination Test Kits Market - Mexico
      • 8.7.4.1. Mexico: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.7.5. Latex Agglutination Test Kits Market - Brazil
      • 8.7.5.1. Brazil: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)
    • 8.7.6. Latex Agglutination Test Kits Market - Argentina
      • 8.7.6.1. Argentina: Latex Agglutination Test Kits Market, by Test Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Latex Agglutination Test Kits Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Latex Agglutination Test Kits Market, by Sample Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Arlington Scientific Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Atlas Medical GmbH
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bio-Rad Laboratories Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Biotec
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Calbiotech
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Creative Diagnostics
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Eurofins Technologies
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Hardly Diagnostics
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. HiMedia Laboratories
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Liofilchem S.r.l.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Mast Group Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Ngaio Diagnostics
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Pro Lab Diagnostics Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Thermo Fisher Scientific
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦